Paradigm REAL-Time Insulin Pump (MMT-522, MMT-722) Recall
Issued April 8, 2026 · Medtronic MiniMed, Inc.
In April 2026, Medtronic MiniMed, Inc. recalled the Paradigm REAL-Time Insulin Pump (MMT-522, MMT-722), a serious health recall reported by the FDA.
Compiled by Maya Ellison, RecallCheckr
What this means for you
All Medtronic MiniMed infusion pumps (Paradigm series, 600 series, and BLE 700 series) were found to be affected by unintended over- and under-delivery of insulin when the pump is elevated or lowered relative to the infusion site, respectively, because of changes in gravitational force impacting hydrostatic and hydrodynamic pressures. Insulin over-delivery, which can occur when the pump is elevated relative to the infusion site, can result in severe hypoglycemia, altered mental status, seizure, coma, or death. An under-delivery of insulin, which can occur at lowered pump height conditions relative to the infusion site, can result in severe hyperglycemia, dehydration, diabetic ketoacidosis, or death.
What you should do
- 1 Stop using Paradigm REAL-Time Insulin Pump (MMT-522, MMT-722) right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact Medtronic MiniMed, Inc. to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Recall details
- Brand
- Medtronic MiniMed, Inc.
- Category
- Health
- Recall date
- April 8, 2026
- Units affected
- Not reported
- Sold at
- Worldwide - US Nationwide distribution including in the states of OR, CA, AZ, NY,TX,FL, OH, MO, TN,NJ, NC, SC, IL, VA, WA, DC, GA, PA, MS,IA
- Recall number
- FDA-Z-1749-2026
- Made in
- United States
- Issuing agency
- FDA
In context
- Medtronic MiniMed, Inc. has 7 recalls in our database.
- We're tracking 3,576 Health recalls in our database.
- This is the 356th Health recall we've logged in 2026.